David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.91% |
| 2 | Technology | 15.8% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Healthcare | 10.16% |
| 5 | Financials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Voyager Therapeutics
VYGR
$214M
| $2.65M | ﹤0.01% |
190,006
+14,620
| +8% | +$213K |
|
2202
CALL
Nutanix
NTNX
$19.2B
| $2.65M | ﹤0.01% |
84,700
| – | – |
|
2203
RLJ Lodging Trust
RLJ
$1.74B
| $2.65M | ﹤0.01% |
149,311
-51,827
| -26% | -$881K |
|
2204
i3 Verticals
IIIV
$297M
| $2.64M | ﹤0.01% |
93,578
-69,984
| -43% | -$1.65M |
|
2205
National Fuel Gas
NFG
$7.89B
| $2.64M | ﹤0.01% |
56,785
+20,455
| +56% | +$933K |
|
2206
PUT
Tapestry
TPR
$24.7B
| $2.64M | ﹤0.01% |
98,000
| – | – |
|
2207
CALL
AerCap
AER
$23.2B
| $2.63M | ﹤0.01% |
42,800
-17,900
| -29% | -$1.05M |
|
|
DRNA
2208
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.63M | ﹤0.01% |
119,270
+97,733
| +454% | +$1.97M |
|
2209
Liberty Media Series A
FWONA
$23.4B
| $2.63M | ﹤0.01% |
62,650
-22,471
| -26% | -$882K |
|
|
IPG
2210
DELISTED
Interpublic Group of Companies
IPG
| $2.62M | ﹤0.01% |
113,522
+88,414
| +352% | +$1.94M |
|
2211
Worthington Enterprises
WOR
$2.84B
| $2.62M | ﹤0.01% |
100,833
+37,306
| +59% | +$878K |
|
2212
CALL
LPL Financial
LPLA
$28.4B
| $2.62M | ﹤0.01% |
+28,400
| New | +$2.44M |
|
2213
TETRA Technologies
TTI
$1.02B
| $2.62M | ﹤0.01% |
1,336,722
-166,174
| -11% | -$267K |
|
2214
CALL
Cincinnati Financial
CINF
$26.3B
| $2.62M | ﹤0.01% |
24,900
-7,300
| -23% | -$798K |
|
2215
PUT
Dow Inc
DOW
$22B
| $2.62M | ﹤0.01% |
47,818
+6,700
| +16% | +$346K |
|
2216
eGain
EGAN
$205M
| $2.61M | ﹤0.01% |
329,903
+86,308
| +35% | +$668K |
|
2217
PUT
HF Sinclair
DINO
$17.5B
| $2.61M | ﹤0.01% |
51,500
-110,100
| -68% | -$5.84M |
|
2218
Vitamin Cottage Natural Grocers
NGVC
$625M
| $2.61M | ﹤0.01% |
264,581
-10,809
| -4% | -$99.3K |
|
2219
CALL
W.P. Carey
WPC
$16.1B
| $2.61M | ﹤0.01% |
33,285
+21,543
| +183% | +$1.81M |
|
|
LSI
2220
DELISTED
Life Storage, Inc.
LSI
| $2.6M | ﹤0.01% |
36,084
-228,240
| -86% | -$16.3M |
|
|
NAV
2221
PUT
DELISTED
Navistar International
NAV
| $2.6M | ﹤0.01% |
90,000
| – | – |
|
2222
Aptiv
APTV
$9.57B
| $2.6M | ﹤0.01% |
27,388
+6,345
| +30% | +$581K |
|
2223
HUB Group
HUBG
$2.46B
| $2.59M | ﹤0.01% |
101,034
-232,320
| -70% | -$5.74M |
|
2224
PUT
Howmet Aerospace
HWM
$106B
| $2.59M | ﹤0.01% |
109,797
+35,860
| +49% | +$801K |
|
|
OTIC
2225
DELISTED
Otonomy, Inc.
OTIC
| $2.59M | ﹤0.01% |
675,400
-155,354
| -19% | -$379K |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw withdrew a net $3.91B in Q4 2019, closing 412 positions and reducing 1,498 holdings. Its most notable exit was Celgene Corp, an estimated $460M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Tesla worth $501M.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.